These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
593 related articles for article (PubMed ID: 27109254)
1. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease. Yin J; Wang C; Huang M; Mao X; Zhou J; Zhang Y Cancer Med; 2016 Jul; 5(7):1654-69. PubMed ID: 27109254 [TBL] [Abstract][Full Text] [Related]
2. Dual roles of CD11b Ni M; Cui J; Yang X; Ding Y; Zhao P; Hu T; Zhan Y; Kang Q; Hu X; Zhao J; Xu Y; Chen L; Liu M; Zhao M; Zhang F; Huang S; Li Y; Yang X; Zhang L; Zhang T; Deng B; Yang B; Lu D; Wang J Front Immunol; 2024; 15():1403272. PubMed ID: 39040102 [TBL] [Abstract][Full Text] [Related]
3. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation. Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747 [TBL] [Abstract][Full Text] [Related]
4. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia. Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100 [TBL] [Abstract][Full Text] [Related]
5. Early myeloid-derived suppressor cells (HLA-DR Wang K; Lv M; Chang YJ; Zhao XY; Zhao XS; Zhang YY; Sun YQ; Wang ZD; Suo P; Zhou Y; Liu D; Zhai SZ; Hong Y; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ J Hematol Oncol; 2019 Mar; 12(1):31. PubMed ID: 30885244 [TBL] [Abstract][Full Text] [Related]
6. CD1d is a novel cell-surface marker for human monocytic myeloid-derived suppressor cells with T cell suppression activity in peripheral blood after allogeneic hematopoietic stem cell transplantation. An B; Lim JY; Jeong S; Shin DM; Choi EY; Min CK; Hong SH Biochem Biophys Res Commun; 2018 Jan; 495(1):519-525. PubMed ID: 29108995 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446 [TBL] [Abstract][Full Text] [Related]
8. Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation. D'Aveni M; Notarantonio AB; Bertrand A; Boulangé L; Pochon C; Rubio MT Front Immunol; 2020; 11():989. PubMed ID: 32528476 [TBL] [Abstract][Full Text] [Related]
9. Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation. Yin J; Li L; Wang C; Zhang Y Int Immunopharmacol; 2020 Nov; 88():106929. PubMed ID: 32889240 [TBL] [Abstract][Full Text] [Related]
10. Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation. Lv M; Zhao XS; Hu Y; Chang YJ; Zhao XY; Kong Y; Zhang XH; Xu LP; Liu KY; Huang XJ Am J Hematol; 2015 Jan; 90(1):E9-E16. PubMed ID: 25303038 [TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation. Lee SE; Lim JY; Kim TW; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Shin DM; Choi EY; Min CK Biol Blood Marrow Transplant; 2018 Jan; 24(1):32-42. PubMed ID: 28844945 [TBL] [Abstract][Full Text] [Related]
12. Enumeration of bone marrow plasmacytoid dendritic cells by multiparameter flow cytometry as a prognostic marker following allogeneic hematopoietic stem cell transplantation. Su RJ; Green R; Chen M Blood Cells Mol Dis; 2018 Mar; 69():107-112. PubMed ID: 29137845 [TBL] [Abstract][Full Text] [Related]
13. Icariin protects against acute graft-versus-host disease while preserving graft-versus-leukemia activity after allogeneic hematopoietic stem cell transplantation. Su L; Wei ZF; Pi CC; Qin TX; Song F; Zhang YW; Gao SJ Phytomedicine; 2024 Sep; 132():155901. PubMed ID: 39067193 [TBL] [Abstract][Full Text] [Related]
14. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation. Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371 [TBL] [Abstract][Full Text] [Related]
15. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation. Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS Front Immunol; 2021; 12():720354. PubMed ID: 34539656 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation. Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G Front Immunol; 2020; 11():1534. PubMed ID: 32849519 [No Abstract] [Full Text] [Related]
17. [The Relationship between Occurrence of aGVHD in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation and Immune Cell Components in Graft]. Liu S; Zhou Z; Zhai WJ; Song XN; Li Q; Jiang EL; Feng SZ; Sun JL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):539-545. PubMed ID: 37096531 [TBL] [Abstract][Full Text] [Related]
18. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156 [TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation. Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744 [TBL] [Abstract][Full Text] [Related]
20. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia]. Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329 [No Abstract] [Full Text] [Related] [Next] [New Search]